HLB Genex Inc
187420
Company Profile
Business description
HLB Genex Inc, formerly GenoFocus Inc is a high-throughput protein evolution company engaged in the development, manufacture, and distribution of enzymes like Lactazyme, chitizyme, and lipase. It develops enzyme solutions for specialty food, eco-friendly processes, biopharmaceuticals, cosmeceuticals, and agriculture.
Contact
65, Techno 1-ro
Yuseong-gu
Daejeon34014
KORT: +82 428624483
Sector
Basic Materials
Stock type
Cyclical
Industry
Specialty Chemicals
Fiscal Year End
31 December 2026
Employees
78
Stocks News & Analysis
stocks
ASX iron ore player downgraded ahead of earnings
Rising costs and delayed production drive fair value cut for ASX iron ore player.
stocks
Global tensions drive profitability for ASX energy provider
Supply disruptions turbocharge refining profits and lift earnings forecasts for ASX energy share.
stocks
ASX energy share undervalued ahead of earnings
Pricing strength outweighs temporary production headwinds.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,405.40 | 59.70 | 0.64% |
| CAC 40 | 8,669.30 | 0.00 | 0.00% |
| DAX 40 | 26,126.30 | 76.05 | -0.29% |
| Dow JONES (US) | 54,349.12 | 263.24 | 0.49% |
| FTSE 100 | 10,888.30 | 8.92 | 0.08% |
| HKSE | 25,915.82 | 62.90 | 0.24% |
| NASDAQ | 26,363.44 | 221.55 | -0.83% |
| Nikkei 225 | 66,300.44 | 2,342.91 | 3.66% |
| NZX 50 Index | 13,997.18 | 93.72 | 0.67% |
| S&P 500 | 7,723.55 | 12.97 | -0.17% |
| S&P/ASX 200 | 9,227.80 | 51.30 | 0.56% |
| SSE Composite Index | 3,878.43 | 56.15 | 1.47% |